This file is part of IDEAS, which uses RePEc data


[ Papers | Articles | Software | Books | Chapters | Authors | Institutions | JEL Classification | NEP reports | Search | New papers by email | Author registration | Rankings | Volunteers | FAQ | Blog | Help! ]

The Work Productivity and Activity Impairment Questionnaire for Patients with Gastroesophageal Reflux Disease (WPAI-GERD): Responsiveness to Change and English Language Validation

Author info | Abstract | Publisher info | Download info | Related research | Statistics
Author Info
Peter Wahlqvist (AstraZeneca R&D, Molndal, Sweden)
Gordon H. Guyatt (McMaster University, Hamilton, Ontario, Canada)
David Armstrong (McMaster University, Hamilton, Ontario, Canada)
Alessio DeglInnocenti (AstraZeneca R&D, Molndal, Sweden)
Diane Heels-Ansdell (McMaster University, Hamilton, Ontario, Canada)
Samer El-Dika (University at Buffalo, State University of New York, Buffalo, New York, USA)
Ingela Wiklund (AstraZeneca R&D, Molndal, Sweden)
Carlo A. Fallone (The McGill University Health Center, McGill University, Montreal, Quebec, Canada)
Lisa Tanser (AstraZeneca Canada, Mississauga, Ontario, Canada)
Sander Veldhuyzen van Zanten (Dalhousie University, Halifax, Nova Scotia, Canada)
Peggy Austin (McMaster University, Hamilton, Ontario, Canada)
Alan N. Barkun (The McGill University Health Center, McGill University, Montreal, Quebec, Canada)
Naoki Chiba (McMaster University, Hamilton, Ontario, Canada)
Holger J. Schunemann (Department of Epidemiology, Italian National Cancer Institute, Regina Elena, Rome, Italy)
Abstract

Background: A validated productivity questionnaire, the Work Productivity and Activity Impairment questionnaire for Gastroesophageal Reflux Disease (WPAI-GERD), exists for Swedish patients with GERD. Objective: To assess responsiveness to change of the WPAI-GERD and construct validity of the English language version. Methods: We used the WPAI-GERD in a before-after treatment clinical study of Canadian GERD patients with moderate or severe symptoms treated with esomeprazole 40mg once daily for 4 weeks. We measured productivity variables including GERD-specific absence from work, reduced productivity while at work and reduced productivity while carrying out regular daily activities other than work during the preceding week. Results: The analysis included 217 patients, of whom 71% (n Cross-sectional correlation coefficients of WPAI variables with symptoms (range 0.04-0.63) and health-related quality of life (HR-QOL; range 0.02-0.65) supported cross-sectional construct validity. Corresponding change score correlations between WPAI variables and HR-QOL (range 0.05-0.56) supported longitudinal construct validity of the WPAI-GERD while low change score correlations between productivity variables and relevant symptoms (range 0.06-0.34) did not. Conclusion: The English version of the WPAI-GERD showed good cross-sectional construct validity, and results indicated that the WPAI-GERD is responsive to change. Although the results also indicated that longitudinal construct validity may be poor, the overall findings suggest that further study of the instrument remains warranted.

Download Info
To download:

If you experience problems downloading a file, check if you have the proper application to view it first. Information about this may be contained in the File-Format links below. In case of further problems read the IDEAS help file. Note that these files are not on the IDEAS site. Please be patient as the files may be large.

File URL: http://pharmacoeconomics.adisonline.com/pt/re/phe/pdfhandler.00019053-200725050-00003.pdf
File Format: application/pdf
File Function:
Download Restriction: Pay per view
File URL: http://pharmacoeconomics.adisonline.com/pt/re/phe/fulltext.00019053-200725050-00003.htm
File Format: text/html
File Function:
Download Restriction: Pay per view

As the access to this document is restricted, you may want to look for a different version under "Related research" (further below) or search for a different version of it.

Publisher Info
Article provided by Wolters Kluwer Health | Adis in its journal PharmacoEconomics.

Volume (Year): 25 (2007)
Issue (Month): 5 ()
Pages: 385-396
Download reference. The following formats are available: HTML, plain text, BibTeX, RIS (EndNote), ReDIF
Handle: RePEc:wkh:phecon:v:25:y:2007:i:5:p:385-396

Contact details of provider:
Web page: http://pharmacoeconomics.adisonline.com/

For technical questions regarding this item, or to correct its listing, contact: (Remco Bouckaert).

Related research
Keywords: Coronary-disorders Gastro-oesophageal-reflux Pharmaceutical-services Randomised-controlled-trials

Find related papers by JEL classification:
C - Mathematical and Quantitative Methods
D - Microeconomics
I - Health, Education, and Welfare
Z - Other Special Topics
I1 - Health, Education, and Welfare - - Health
I19 - Health, Education, and Welfare - - Health - - - Other
I18 - Health, Education, and Welfare - - Health - - - Government Policy; Regulation; Public Health
I11 - Health, Education, and Welfare - - Health - - - Analysis of Health Care Markets

Statistics
Access and download statistics

Did you know? You can create a compilation of all publications of a group of people, say alumni of a program, your students or memers of an association.

This page was last updated on 2008-4-27.


This information is provided to you by IDEAS at the Department of Economics, College of Liberal Arts and Sciences, University of Connecticut using RePEc data on a server sponsored by the Society for Economic Dynamics.